Intelligent Bio Solutions Statistics
Total Valuation
INBS has a market cap or net worth of $5.26 million. The enterprise value is $6.43 million.
Important Dates
The next estimated earnings date is Friday, May 8, 2026, before market open.
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
INBS has 2.18 million shares outstanding. The number of shares has increased by 126.93% in one year.
| Current Share Class | 2.18M |
| Shares Outstanding | 2.18M |
| Shares Change (YoY) | +126.93% |
| Shares Change (QoQ) | +11.25% |
| Owned by Insiders (%) | 4.16% |
| Owned by Institutions (%) | 2.37% |
| Float | 2.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.46 |
| Forward PS | 0.32 |
| PB Ratio | 0.27 |
| P/TBV Ratio | 0.67 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.80 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.18.
| Current Ratio | 2.37 |
| Quick Ratio | 2.17 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -126.58 |
Financial Efficiency
Return on equity (ROE) is -150.20% and return on invested capital (ROIC) is -76.38%.
| Return on Equity (ROE) | -150.20% |
| Return on Assets (ROA) | -51.17% |
| Return on Invested Capital (ROIC) | -76.38% |
| Return on Capital Employed (ROCE) | -86.07% |
| Weighted Average Cost of Capital (WACC) | 22.54% |
| Revenue Per Employee | $65,115 |
| Profits Per Employee | -$205,350 |
| Employee Count | 55 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 2.98 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.27% in the last 52 weeks. The beta is 4.59, so INBS's price volatility has been higher than the market average.
| Beta (5Y) | 4.59 |
| 52-Week Price Change | -81.27% |
| 50-Day Moving Average | 3.46 |
| 200-Day Moving Average | 9.42 |
| Relative Strength Index (RSI) | 32.88 |
| Average Volume (20 Days) | 129,987 |
Short Selling Information
The latest short interest is 27,026, so 1.24% of the outstanding shares have been sold short.
| Short Interest | 27,026 |
| Short Previous Month | 44,510 |
| Short % of Shares Out | 1.24% |
| Short % of Float | 1.30% |
| Short Ratio (days to cover) | 0.30 |
Income Statement
In the last 12 months, INBS had revenue of $3.58 million and -$11.29 million in losses. Loss per share was -$14.67.
| Revenue | 3.58M |
| Gross Profit | 1.65M |
| Operating Income | -10.78M |
| Pretax Income | -11.33M |
| Net Income | -11.29M |
| EBITDA | -9.84M |
| EBIT | -10.78M |
| Loss Per Share | -$14.67 |
Full Income StatementBalance Sheet
The company has $740,371 in cash and $1.92 million in debt, giving a net cash position of -$1.18 million or -$0.54 per share.
| Cash & Cash Equivalents | 740,371 |
| Total Debt | 1.92M |
| Net Cash | -1.18M |
| Net Cash Per Share | -$0.54 |
| Equity (Book Value) | 10.89M |
| Book Value Per Share | 8.96 |
| Working Capital | 7.05M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$9.38 million and capital expenditures -$361,535, giving a free cash flow of -$9.74 million.
| Operating Cash Flow | -9.38M |
| Capital Expenditures | -361,535 |
| Depreciation & Amortization | 944,645 |
| Net Borrowing | n/a |
| Free Cash Flow | -9.74M |
| FCF Per Share | -$4.47 |
Full Cash Flow StatementMargins
| Gross Margin | 46.21% |
| Operating Margin | -301.04% |
| Pretax Margin | -316.50% |
| Profit Margin | n/a |
| EBITDA Margin | -274.66% |
| EBIT Margin | n/a |
| FCF Margin | n/a |